Oaktree Acquisition Corp III Life Sciences Warrant
OACCW
27 hedge funds and large institutions have $2.65M invested in Oaktree Acquisition Corp III Life Sciences Warrant in 2026 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
28% more capital invested
Capital invested by funds: $2.07M → $2.65M (+$585K)
4% more funds holding
Funds holding: 26 → 27 (+1)
0.94% more ownership
Funds ownership: 73.39% → 74.33% (+0.94%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPC
Lineage Point Capital
Palm Beach,
Florida
|
+$66.3K |
| 2 |
DAM
DLD Asset Management
New York
|
+$37.4K |
| 3 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$14K |
| 4 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
+$1.1K |
| 5 |
CS
Clear Street
New York
|
+$335 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LIP
Lighthouse Investment Partners
Palm Beach Gardens,
Florida
|
-$45K |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
-$29.5K |
| 3 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$10.6K |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
-$472 |
OACCW Hedge Fund Activity: Q2 2026 in Review
27 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) for Q2 2026, worth a combined $2.65M — up 28% from $2.07M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new OACCW positions and 1 closed out — a net gain of 2 holders — while 4 added to existing stakes and 3 trimmed.
The largest buyer was Lineage Point Capital, opening a new position worth an estimated $66.3K. The largest seller was Lighthouse Investment Partners, exiting entirely with an estimated $45K sold.
- 27 institutional investors held Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) as of Q2 2026, up from 26 in Q1 2026.
- Funds reported $2.65M of Oaktree Acquisition Corp III Life Sciences Warrant stock for Q2 2026, up 28% quarter-over-quarter.
- 3 funds opened new Oaktree Acquisition Corp III Life Sciences Warrant positions in Q2 2026 and 1 closed out, a net change of +2 holders.
- The largest Oaktree Acquisition Corp III Life Sciences Warrant buyer in Q2 2026 was Lineage Point Capital, an estimated $66.3K added.
- The largest Oaktree Acquisition Corp III Life Sciences Warrant seller in Q2 2026 was Lighthouse Investment Partners, an estimated $45K sold.
Based on aggregated 13F filings for Q2 2026.